← Back
$STOK All transactions

Stoke Therapeutics, Inc.

M

$ Value

$0

Shares

26,250

Price

$0

Filed

Mar 17

Insider

Name

Kaye Edward M. MD

Title

CIK

0001522780

Roles

Director

Transaction Details

Transaction Date

2026-03-15

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

110,874

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. | The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date. | The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the Issuer through each vesting date.

Filing Info

Accession No.

0001522780-26-000002

Form Type

4

Issuer CIK

0001623526

Kaye Edward M. MD's History

Date Ticker Type Value
2026-04-15 CYTK A $12K
2026-03-15 STOK M $0
2026-03-15 STOK M $0
2026-03-15 STOK M $0
2026-03-15 STOK M $0
2026-02-27 RNAM D
2026-02-27 RNAM D
2026-02-27 RNAM D
2026-02-27 RNAM D
2026-02-27 RNAM D

Other Insiders at STOK (90d)

Insider Bought Sold Last
LEVIN ARTHUR A $22K 2026-03-13
SMITH IAN F
Chief Executive Officer
2026-02-17
Kaye Edward M. MD 2026-03-15
TZIANABOS ARTHUR
Interim Executive Chair
$174K 2026-03-10
Hoitt Jason
Chief Patient Officer
$119K 2026-03-18
Leggett Thomas
Chief Financial Officer
$147K 2026-03-18
Krainer Adrian R. $1.6M 2026-03-10
Ticho Barry
CHIEF MEDICAL OFFICER
$517K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$599K 2026-03-20